These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 27514242

  • 1. Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism.
    Bruno VA, Fox SH, Mancini D, Miyasaki JM.
    Can J Neurol Sci; 2016 Sep; 43(5):697-702. PubMed ID: 27514242
    [Abstract] [Full Text] [Related]

  • 2. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients.
    Pullman SL, Greene P, Fahn S, Pedersen SF.
    Arch Neurol; 1996 Jul; 53(7):617-24. PubMed ID: 8929169
    [Abstract] [Full Text] [Related]

  • 3. Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling.
    Lagalla G, Millevolte M, Capecci M, Provinciali L, Ceravolo MG.
    J Neurol; 2009 Apr; 256(4):563-7. PubMed ID: 19401804
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin treatment of lateral axial dystonia in Parkinsonism.
    Bonanni L, Thomas A, Varanese S, Scorrano V, Onofrj M.
    Mov Disord; 2007 Oct 31; 22(14):2097-103. PubMed ID: 17685467
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.
    Mancini F, Zangaglia R, Cristina S, Sommaruga MG, Martignoni E, Nappi G, Pacchetti C.
    Mov Disord; 2003 Jun 31; 18(6):685-8. PubMed ID: 12784273
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Botulinum toxin in the management of parkinsonian disorders.
    Grippe T, Chen R.
    Toxicon; 2023 Aug 15; 232():107209. PubMed ID: 37429465
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin.
    Pacchetti C, Albani G, Martignoni E, Godi L, Alfonsi E, Nappi G.
    Mov Disord; 1995 May 15; 10(3):333-6. PubMed ID: 7651452
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Botulinum Toxin-A Injection in Chronic Pelvic Pain Syndrome Treatment: A Systematic Review and Pooled Meta-Analysis.
    Panunzio A, Tafuri A, Mazzucato G, Cerrato C, Orlando R, Pagliarulo V, Antonelli A, Cerruto MA.
    Toxins (Basel); 2022 Jan 01; 14(1):. PubMed ID: 35051002
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Botulinum toxin reduces Dysphagia in patients with nonachalasia primary esophageal motility disorders.
    Vanuytsel T, Bisschops R, Farré R, Pauwels A, Holvoet L, Arts J, Caenepeel P, De Wulf D, Mimidis K, Rommel N, Tack J.
    Clin Gastroenterol Hepatol; 2013 Sep 01; 11(9):1115-1121.e2. PubMed ID: 23591282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.